Skip to main content
. 2021 Aug 28;43(2):996–1018. doi: 10.3390/cimb43020071
ADT androgen deprivation therapy
Con A concanavalin A
CRPC castration-resistant prostate cancer
DEX dexamethasone
DMSO dimethyl sulfoxide
ELISA enzyme-linked immuno-sorbent assay
ER Euodia ruticarpa
ERF1-F6 ER SDEO fraction 1–6
GC-MS gas chromatography–mass spectrometry
IL interleukin
LPS lipopolysaccharide
MCM macrophage-conditioned medium
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
SCM splenocyte-conditioned medium
SDEO steam distilled essential oil
Th1 T helper type 1 lymphocyte
Th2 T helper type 2 lymphocyte
TNF tumor necrosis factor